Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.048 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |